CompletedPhase 1NCT04747964

A Safety Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor

Studying Hemophilia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Principal Investigator
Lei Zhang
Chinese Academy of Medical Sciences
Intervention
STSP-0601 for Injection(drug)
Enrollment
16 enrolled
Eligibility
18-65 years · MALE
Timeline
2020 – 2021

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04747964 on ClinicalTrials.gov

Other trials for Hemophilia

Additional recruiting or active studies for the same condition.

See all trials for Hemophilia →

← Back to all trials